Show simple item record

dc.contributor.authorLamarca, Angela
dc.contributor.authorWalter, T
dc.contributor.authorPavel, M
dc.contributor.authorBorbath, I
dc.contributor.authorFreis, P
dc.contributor.authorNuñez, B
dc.contributor.authorChilds, A
dc.contributor.authorMcNamara, Mairéad G
dc.contributor.authorHubner, Richard A
dc.contributor.authorGarcia-Carbonero, R
dc.contributor.authorMeyer, T
dc.contributor.authorValle, Juan W
dc.contributor.authorBarriuso, Jorge
dc.date.accessioned2017-03-04T18:37:36Z
dc.date.available2017-03-04T18:37:36Z
dc.date.issued2017-01
dc.identifier.citationDesign and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas. 2017, 109(5): J Natl Cancer Insten
dc.identifier.issn1460-2105
dc.identifier.pmid28130474
dc.identifier.doi10.1093/jnci/djw277
dc.identifier.urihttp://hdl.handle.net/10541/620169
dc.description.abstractPrognostic markers for risk stratification of patients with gastrointestinal high-grade neuroendocrine carcinomas (GI-NECs) are lacking; we designed and validated a prognostic score for overall survival (OS).
dc.language.isoenen
dc.rightsArchived with thanks to Journal of the National Cancer Instituteen
dc.titleDesign and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, The Christie NHS Foundation Trust (ENETS Centre of Excellence), Manchester, UKen
dc.identifier.journalJournal of the National Cancer Instituteen
html.description.abstractPrognostic markers for risk stratification of patients with gastrointestinal high-grade neuroendocrine carcinomas (GI-NECs) are lacking; we designed and validated a prognostic score for overall survival (OS).


This item appears in the following Collection(s)

Show simple item record